Use of Information
We grant you a limited, revocable, and non-exclusive license to access and make personal, non-commercial use of the Website. You have no rights in or to the Information, and you will not use, copy or display the Information, except as permitted under these Terms. No other use is permitted without our prior written consent. Unauthorized use of the Information may result in violation of copyright, trademark, and other laws.
Copyright & Trademarks
Preprogen, Pro Women. Pro Health.™, and the Preprogen logo are trademarks of Preprogen. Use, reproduction, copying, or redistribution of these trademarks, without the written permission of Preprogen is prohibited. Other trademarks are owned or used under license by their respective owners. The entire content of this Preprogen website, including any images or text, is protected by copyright. In consideration for your agreement to these terms and conditions, Preprogen grants you a personal, non-exclusive, non-transferable license to access and use this website. It is the policy of Preprogen to enforce its intellectual property rights to the fullest extent permitted under law. The use or misuse of these trademarks, copyrights, or other materials, except as permitted herein, is expressly prohibited and may be in violation of copyright law, trademark law, communications regulations and statutes, and other laws, statutes, and/or regulations.
This Website provides information on various health topics and may become out of date over time. The Website is not intended to provide any medical advice and should not be considered such.
Preprogen’s Website may contain links to websites operated and maintained by other parties (external websites). Preprogen is not responsible for the content of any external websites, and links to these sites are not an endorsement of the content. Preprogen does not make any representation regarding the accuracy of content on external websites.
This Website contains forward-looking statements concerning Preprogen within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Those forward-looking statements include, without limitation, statements regarding the Company’s expectations for the growth of the Company’s operations and revenue. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements.
Factors that could cause or contribute to differences include, but are not limited to, results of upcoming clinical trials, customer demand for our products and market prices; the outcome of our ongoing research and developments efforts relating to our pharmaceutical products; our ability to develop the sales force required to achieve our business objectives. Preprogen does not undertake, and specifically disclaims any obligation to update or revise such statements made herein to reflect new circumstances or unanticipated events as they occur.
News & Press Releases
This Preprogen Website may contain information, news, and/or press releases, the content of which is accurate or current only as of the date of the particular information, news, press release, or posting. Preprogen does not update press releases once they have been made public.
Preprogen’s Social Media Community Guidelines
Welcome to Preprogen’s corporate social media channels – Facebook, Twitter, YouTube and Instagram. We use our communities to share stories that are Pro Women. Pro Health.™ around the world, as well as Preprogen’s company and employer news.
We invite you to be part of our community and engage with us. However, when we see mentions of and replies to our pages, we ask that you follow these Community Guidelines to ensure we provide you with the best experience.
Please remember that we work in a highly regulated industry with unique legal considerations. Because of this, there are topics, and discussions about our products, other companies’ products, medical advice or treatment options that we will not respond to. These discussions are best held in private with a health care professional.
Because of these regulations, please keep conversations on‐topic and constructive. For this reason, we may hide or not respond to mentions, direct messages, or replies that:
Please be aware that those who violate the above rules may have their replies hidden, comments reported, or be blocked on our accounts.
Please keep conversations positive, supportive and on-topic. And thank you for being part of our community.
Using and storing personal identifying information
Preprogen will not disclose or share personal identifying information on its social media handles unless we have obtained proper consents. We do not store or use your social media profile unique ID, email, or other personal identifying information. However, in the case of reporting a side effect or product issue, we will need to store and use personal identifying information, such as your name, location, health‐related information or similar, in accordance with applicable laws. This information is required to be submitted to the Preprogen Patient Safety department and/or regulatory authorities. We are also required to store your personal identifying information for auditing purposes.
In some instances, Preprogen may choose to use third‐party service providers to help us manage comments and messages, which means that they too would have access to any personal identifying information you share with us. Such third‐party service providers are contractually bound and trained to ensure an adequate protection and security of your personal identifying information.
Thank you for reading and being part of our community.